Home » Newsletters » BioWorld Asia

BioWorld Asia

May 20, 1998

View Archived Issues

Herpes Protein May Boost Gene Therapy Delivery Systems

Flamel Generates $10M To Support Drug Delivery

Theratechnologies Signs Major Alliance With Genetix

British Biotech's McCullagh To Resign Amid Controversy

Biota Shares Jump On FDA Filing

European Parliament Approves Stronger Patent Protections

Wellcome Counters Efforts In US To Control Genome Discoveries

Biotech International Gets Control Of Agen In A$18M Takeover

Vanguard On Track With Migraine Drug Despite Loss Of SmithKline

Phytopharm Begins Phase II For Osteoarthritis Treatment

Dendritic Cell Exosomes Function As Vaccine Vectors

Icon IPO Generates US$50M For Clinical Trial Services

Xenova Takes Anti-MDR Therapy Into Phase I Cancer Trials

Scotia Founder Departs In Dispute With New CEO

Cortecs Signs Glaxo Deal For Macritonin In Greece

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...